Bavencio Interactions
There are 593 drugs known to interact with Bavencio (avelumab), along with 10 disease interactions. Of the total drug interactions, 3 are major, and 590 are moderate.
- View all 593 medications that may interact with Bavencio
- View Bavencio disease interactions (10)
Most frequently checked interactions
View interaction reports for Bavencio (avelumab) and the medicines listed below.
- Abilify MyCite (aripiprazole)
- Actemra (tocilizumab)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adempas (riociguat)
- Adriamycin (doxorubicin)
- Advair Diskus (fluticasone / salmeterol)
- Advate (antihemophilic factor)
- Afinitor Disperz (everolimus)
- Afstyla (antihemophilic factor)
- Aggrenox (aspirin / dipyridamole)
- Akynzeo (netupitant / palonosetron)
- Aldurazyme (laronidase)
- Alimta (pemetrexed)
- alprazolam
- Alprazolam Intensol (alprazolam)
- Amicar (aminocaproic acid)
- amoxicillin
- Apresazide (hydralazine / hydrochlorothiazide)
- Aptivus (tipranavir)
- Arava (leflunomide)
- Aricept (donepezil)
- Arzerra (ofatumumab)
- Asendin (amoxapine)
- Combivent Respimat (albuterol / ipratropium)
- DuoNeb (albuterol / ipratropium)
- Lyrica (pregabalin)
- Sabril (vigabatrin)
- Symbicort (budesonide / formoterol)
- Tecentriq (atezolizumab)
Bavencio disease interactions
There are 10 disease interactions with Bavencio (avelumab) which include:
- hepatic impairment
- adrenal insufficiency
- colitis
- diabetes
- pneumonitis
- renal dysfunction
- thyroid disease
- HSCT
- myasthenia gravis
- organ transplant
Report options
More about Bavencio (avelumab)
- Bavencio consumer information
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Keytruda
Keytruda is used to treat multiple types of cancer such as melanoma, non-small cell lung cancer ...
Avastin
Avastin is used to brain tumors and cancers of the kidney, colon, rectum, or lung. Learn about side ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Opdivo
Opdivo is used to treat many cancers, such as melanoma, non-small cell lung cancer, malignant ...
Lenvima
Lenvima (lenvatinib) is used to treat thyroid cancer, advanced renal cell carcinoma, hepatocellular ...
Lenvatinib
Lenvatinib is used to treat thyroid cancer, kidney cancer, liver cancer, and advanced endometrial ...
Everolimus
Everolimus (Afinitor, Afinitor Disperz, Zortress) belongs to a class of drugs called kinase ...
Nivolumab
Nivolumab (brand name Opdivo) is an immunotherapy treatment that treats many cancers, such as ...
Bevacizumab
Bevacizumab injection is a targeted cancer drug used to treat types of non-small cell lung cancer ...
Pembrolizumab
Pembrolizumab (Keytruda) is a monoclonal antibody cancer medicine used to treat
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
